Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Kuang Yang

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Plos One|September 6, 2024
Impact of different visceral metastatic sites on survival in metastatic prostate cancer patientsGu-Shun Lai, Chuan-Shu Chen, Jason Chia-Hsien Cheng, et al.
Anticancer Research|October 3, 2022
Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective StudyJian-Ri Li, Shian-Shiang Wang, Chuan-Shu Chen, et al.
Anticancer Research|June 23, 2023
Metastasectomy Improves Overall Survival in Metastatic Renal Cell Carcinoma: A Retrospective Cohort StudyJiun-Kai Chiou, Li-Wen Chang, Jian-Ri Li, et al.
Anticancer Research|December 30, 2022
Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate HyperplasiaLi-Wen Chang, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Asian Journal of Surgery|September 6, 2023
Robotic partial nephrectomy for renal tumor: The pentafecta outcomes of a single surgeon experienceBo-Ren Wang, Yen-Chuan Ou, Li-Hua Huang, et al.
Anticancer Research|June 29, 2026
Real-world Comparison of Avelumab Maintenance and Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial CarcinomaTsung-Han Yen, Shian-Shiang Wang, Chaun-Shu Chen, et al.
Urologic Oncology|June 4, 2019
Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsyChia-Yen Lin, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Anticancer Research|July 3, 2019
Abiraterone Acetate and Enzalutamide: Similar Efficacy in Treating Post Docetaxel Metastatic Castration-resistant Prostate Cancer: Single Center ExperienceLi-Wen Chang, Sheng-Chun Hung, Shian-Shiang Wang, et al.
Journal of the Chinese Medical Association : JCMA|December 27, 2011
PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsyChuan-Shu Chen, Shian-Shiang Wang, Jian-Ri Li, et al.
International Journal of Medical Sciences|November 2, 2019
Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristicsChia-Yen Lin, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Plos One|September 6, 2024
Impact of different visceral metastatic sites on survival in metastatic prostate cancer patientsGu-Shun Lai, Chuan-Shu Chen, Jason Chia-Hsien Cheng, et al.
Anticancer Research|October 3, 2022
Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective StudyJian-Ri Li, Shian-Shiang Wang, Chuan-Shu Chen, et al.
Anticancer Research|June 23, 2023
Metastasectomy Improves Overall Survival in Metastatic Renal Cell Carcinoma: A Retrospective Cohort StudyJiun-Kai Chiou, Li-Wen Chang, Jian-Ri Li, et al.
Anticancer Research|December 30, 2022
Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate HyperplasiaLi-Wen Chang, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Asian Journal of Surgery|September 6, 2023
Robotic partial nephrectomy for renal tumor: The pentafecta outcomes of a single surgeon experienceBo-Ren Wang, Yen-Chuan Ou, Li-Hua Huang, et al.
Anticancer Research|June 29, 2026
Real-world Comparison of Avelumab Maintenance and Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial CarcinomaTsung-Han Yen, Shian-Shiang Wang, Chaun-Shu Chen, et al.
Urologic Oncology|June 4, 2019
Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsyChia-Yen Lin, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Anticancer Research|July 3, 2019
Abiraterone Acetate and Enzalutamide: Similar Efficacy in Treating Post Docetaxel Metastatic Castration-resistant Prostate Cancer: Single Center ExperienceLi-Wen Chang, Sheng-Chun Hung, Shian-Shiang Wang, et al.
Journal of the Chinese Medical Association : JCMA|December 27, 2011
PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsyChuan-Shu Chen, Shian-Shiang Wang, Jian-Ri Li, et al.
International Journal of Medical Sciences|November 2, 2019
Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristicsChia-Yen Lin, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Pageof 8